Supplier sign in
Home
STAY INFORMED
Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.

     

News items March 2019

Post your news
Eusoft is ISO 27100 certified
Eusoft is ISO 27100 certified
We are very proud to announce that we are ISO 27001 certified. The International Organization for Standardization (ISO) is an independent, international organization that sets the global standards for security and safety. In short, ISO consults experts all over the world to create standards that define what excellence looks like. ISO 27001 is a part of the ISO 27000 family of standards, which are all related to information security. ISO 27001 requires a company to have an information security management system, which means having a documented process for managing sensitive company information, HR processes, and IT systems. An independent assessment was conducted by the ISO Certification Body Dnv gl business Assurance S.r.l. and demonstrates our commitment to information security. The path to certification took place with the close involvement of all employees, who were actively prepared for their tasks and duties within the framework of ISO 27001 in several training
29-03-2019  |  544x  |  Industry news  | 
CPhI Japan sees Japanese R&D reinvigorated
Generics consumption increasing, and the removal of long-list products opens up funding Tokyo, 25th March 2019: CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. A focus on removing long-list products, and the increased use of generics has seen capital re-directed into R&D – with Takeda-Shire now possessing the world’s second largest pipeline of drug targets (211). In a ground-breaking session at the event, Ian Haydock, Editor-In-Chief, Asia Pacific Informa Intelligence, highlighted how Japan has taken a lead in providing a supporting regulatory environment for orphan indications through its AMED programme. Additionally, Japan is also simultaneously emerging as a particularly prominent ecosystem for cell and gene therapy innovators. What is most significant about the trends highlighted at CPhI Japan is that a consensus seems to be emerging for the removal of long-listed products. Long promoted as an anti-innovation strategy, it is increasingly viewed as an approach that is helping
28-03-2019  |  299x  |  Industry news
WuXi STA’s manufacturing facility passes Mpa gmp inspection
SHANGHAI, March 27, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its new drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European Medical Products Agency (MPA). The new facility was opened at the end of 2018, and the successful inspection demonstrates the outstanding quality control system and rapid development of WuXi STA’s drug product services. In 2017, WuXi STA merged with WuXi AppTec’s Pharmaceutical Development Services unit, realizing a seamless integration of chemistry, manufacturing and control (CMC) services. Two new commercial drug product facilities – in Shanghai and Wuxi City – have come into operation, enabling WuXi STA to support solid dosage drug development from preclinical to commercial, with several phase III and commercial drug product projects underway. WuXi STA has received FDA inspections at both its API and advanced intermediate
27-03-2019  |  313x  |  Industry news
Labelling chemicals has never been easier
Labelling chemicals has never been easier
Quickly print GHS/CLP-labels The BradyJet J2000 takes printing reliable GHS/CLP labels at your location to a new level. The printer's advanced full colour inkjet technology can quickly turn a wide range of blank label materials and label sizes into compliant GHS/CLP labels to identify chemicals. With its automatic label setup technology, the BradyJet J2000 can start printing on a new label size within seconds, saving customers time, stress and hassle. Easy compliance When combined with our GHS app, the BradyJet J2000 becomes an even more powerful tool to properly identify any chemical. The Brady Workstation GHS label app enables you to select chemicals by name or CAS-number. The app then automatically populates all required fields to design a compliant GHS/CLP label. Required fields include: • product name • signal word • GHS-pictograms • hazard statements • precautionary statements Extremely
26-03-2019  |  429x  |  Industry news  | 
WuXi STA forms Strategic Partnership with Beta Pharma
STA will accelerate process R&D and manufacturing of late phase and commercial targets STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Beta Pharma, a biotech company focusing on innovative drug discovery and development in oncology, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Beta Pharma, leveraging its platform to accelerate process R&D and manufacturing of later phase and commercial production – utilizing the Marketing Authorization Holder (MAH) scheme. Beta Pharma is an emerging specialty pharmaceutical company dedicated to the discovery, development, and commercialization of innovative late stage therapies targeting oncology. The company has a pedigree spanning some 20 years and its founder Dr. Xiaodong Zhang even participated in the molecular invention, development and listing in China of the first small molecule targeted anticancer drug, Icotinib. Today, Beta Pharma continues to expand its pipeline to integrate anticancer drugs and therapies,
22-03-2019  |  317x  |  Industry news
Pharmapack success points to sizeable growth potential
Paris, 19th March 2019: The drug delivery and healthcare packaging industry is set for significant growth in 2019 as Pharmapack Europe (#pharmapackeu) – a key bellwether of industry health – welcomed a record 410 exhibiting companies and nearly 5,500 attendees from 75 countries. Europe’s biggest pharmaceutical packaging and drug delivery event (Paris Expo, Porte de Versailles, France 6-7 February, 2019) saw a diversification of innovations and new drug delivery solutions, with ‘patient-centricity’ emerging as the central theme throughout this year’s edition. The event played host to some of the hottest emerging innovators in the Start-up hub – showcasing new technologies from AI development platforms and advanced data analytics to miniaturised packaging sensors, soft mist inhalers, and smart packaging. Pharmapack is widely acknowledged as a window into upcoming industry trends with sustainability, eco-friendly packaging and smart packaging in particular earmarked
22-03-2019  |  310x  |  Industry news
PLA2019 – See what you cannot miss Good reasons to subscribe to the Paperless Lab Academy 2019
PLA2019 – See what you cannot miss
Good reasons to subscribe to the Paperless Lab Academy 2019 “The Paperless Lab Academy is the greatest European congress where to deepen in laboratory data management related concepts and methodologies” This is what our attendees’ comment every year." As such, we keep working on maintaining the momentum and have set for the 7th edition a central theme that will strongly focus on the digital transformation process with a holistic approach covering the complete #eDataLifeCycle. We´ll discuss topics related to what we like to define the four main phases of the data life cycle: #eConnect, #eManage, #eDecide and #eArchive. The event is a learning platform for those considering consolidating, integrating and simplifying scientific data management systems and processes. A platform where experiences and expertise are shared, where discussion generates food for thoughts on how to convert the so valuable scientific data generated in the laboratory to actionable insights for the company. Ultimate goal is to turn your laboratory
21-03-2019  |  320x  |  Industry news  | 
New built-in syringe pump: Precision-SY
New built-in syringe pump: Precision-SY
SPETEC GmbH is presenting a new product. The Precision-SY OEM built-in syringe pump was specially developed for use in equipment where high precision in the microliter and nanoliter range is required when introducing samples or reagents. It is specially matched to the requirements of the analysis equipment, i.e. the shape and colour of the mounting plate are tailored to customer requirements. The core elements of the pumps are a stepper motor, a spindle, a linear guideway, a syringe holder and replaceable syringes. Thanks to the high stepper motor resolution of 25,600 steps per revolution, individual steps during the movement sequence are barely perceptible. A connecting element that forms a rigid connection between the spindle and the syringe plunger transmits the drive force from the stepper motor, thus delivering the feed motion for filling or emptying the syringe. Metering syringes with volumes between 0.05 ml and 10 ml are used. It is optionally available with
15-03-2019  |  664x  |  Product news  | 
Fast analysis of particle shape and size  Fast. Safe. Easy. - Discover the Possibilities!
Fast analysis of particle shape and size
Fast. Safe. Easy. - Discover the Possibilities! The Fritsch analysette 28 ImageSizer for dry and wet measurement is the ideal Particle Sizer for all applications that require accurate and reproducible measuring results for both particle shape and size. The optical process of Dynamic Image Analysis provides results for a wide measuring range, delivers multiple shape parameters and evaluation possibilities for particle size. The measuring time depending on the sample quantity, is under 5 minutes. And the result is available immediately. Your advantage: Great flexibility for different measurement tasks for particle sizes of 20 µm – 20 mm in quality control, research and laboratory – and is a very easy and cost-effective alternative to sieving. - Easy wet measurement of suspensions and emulsions - The Analysette 28 ImageSizer is in combination with the corresponding wet dispersion unit ideal for measurement of particle shape and size of suspensions and emulsions. - Wet dispersion is particularly suitable
13-03-2019  |  343x  |  Product news  | 
SP2000 robotic platform  for automatic sample filtration, analysis and distribution
SP2000 robotic platform
for automatic sample filtration, analysis and distribution Skalar has automated the sample filtration of water samples, followed by the measurement of conductivity (EC) / pH and the sample distribution to several destination racks for further analysis on other analyzers. The SP2000 analyzer holds 1 rack with 30 bottles for the original water samples, 1 rack with 30 empty bottles for filtered water samples and various destination racks with empty vials and tubes. The robot is configured with various stirrers, dispensers, pipetting needles, pH probe, conductivity flow cell and paperband filter. The SP2000 automated procedure: The sample rack and destination racks are loaded onto the SP2000 platform. A sample analysis table is created and the analyzer is started. The first sample is homogenized and then pumped through a paper band filter for sample filtration. After filtration, the sample is pumped via a flow cell to measure the conductivity, in an empty bottle. When all samples have been filtered and measured
12-03-2019  |  487x  |  Product news  |   | 
BioAgilytix Europe appoints new Scientific Officer
BioAgilytix Europe appoints new Scientific Officer
BioAgilytix, a leading global bioanalytical testing laboratory specializing in the bioanalysis of biopharmaceuticals, is pleased to announce the appointment of its new Scientific Officer for BioAgilytix Europe, Dr Lydia Michaut. Lydia brings a wealth of experience in immunology, genetics, gene therapy and regulated bioanalysis to the company, and is perfectly placed to liaise with clients to ensure that BioAgilytix delivers high quality laboratory services tailored to their specific needs. Passionate about life sciences, Lydia obtained a PhD in molecular biology and innate immunity from Louis Pasteur University, Strasbourg – where she studied with Nobel Laureate Professor Jules Hoffmann – before taking up a postdoctoral position with the world-renowned developmental biologist Professor Walter Gehring at Biozentrum, University of Basel. After 15 years in academia, Lydia moved to Swiss pharma company Novartis, where she became one of the first members of staff dedicated
12-03-2019  |  428x  |  Industry news  | 
Envigo launches PATHWAY
11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of Pathway – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials. Pathway is designed to manage the complexity of the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers by integrating safety assessment study types and bioanalytical support with scientific and regulatory consulting, program design and project management. The decision to develop the Pathway solution was made in order to help our customers navigate the increased scientific and regulatory complexity facing advanced therapies going through safety assessment. The intricacy of design and management of these critical non-clinical programs, and the level of interaction with regulatory bodies required, raises the risk of introducing delays
11-03-2019  |  324x  |  Industry news
WuXi STA and Ark Biosciences Sign CMC agreement
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and development, especially in the area of viral infection and respiratory disease, today announced a strategic partnership for CMC development and manufacturing. Under the terms of the collaboration, Ark Biosciences will utilize the Marketing Authorization Holder (MAH) scheme to accelerate drug development and WuXi STA will provide an integrated solution in process R&D and manufacturing. Ark Biosciences’ pipeline includes active discovery programs of its own, those of its partners, as well as in-licensed drug assets for clinical development. Ark’s leading program, a novel respiratory syncytial virus (RSV) F-protein inhibitor Ziresovir (AK0529), has completed three phase I clinical trials and is currently in global multi-center phase II clinical trial. The company also entered into a license agreement with
08-03-2019  |  289x  |  Industry news
Industry Experts Combine to Create Safer Intravenous Deliver
The Italian Biochemical Institute, Comecer, and Particle Measuring Systems share expertise to develop and manufacture a safer intravenous solution. March 5, 2019 Rome, Italy – The Italian Biochemical Institute (IBI) ”Lorenzini”, Comecer, and Particle Measuring Systems (PMS) recently partnered to leverage and combine the expertise of each entity to design a new drug delivery system and a filling line to safely and effectively manufacture it. A Quality Risk Management (QRM) approach was used as the basis to meet the distinctive needs of the aseptic filling line and ensure that regulatory needs were met. This partnership started when IBI designed a new approach to drug infusions deliveries, patented as “Espresso®”. “Espresso was created to ensure the safe delivery of sterile intravenous medication to patients”, said J. Khevenhüller, CEO at The Italian Biochemical Institute (IBI). “Following the initial project, we needed a way to safely mass produce Espresso. However,
08-03-2019  |  244x  |  Industry news
Come and see us at Laborama 2019 Stand E15!
Come and see us at Laborama 2019
Stand E15! Discover how we can help you save money in Chromatography & Mass Spectrometry and get a chance at ”What’s in the (Quiet)Box?” And win an Amazon gift voucher!
07-03-2019  |  273x  |  Industry news  | 
Innovation award for Vaisala viewLinc system Vaisala’s Wireless viewLinc Monitoring System Received Quality Innovation Award
Innovation award for Vaisala viewLinc system
Vaisala’s Wireless viewLinc Monitoring System Received Quality Innovation Award Vaisala, the global leader in environmental and industrial measurements, has won the annual Global Quality Innovation Award 2018 with its wireless viewLinc Continuous Monitoring System. Vaisala’s viewLinc was awarded for its usability and reliable system design, which is utilizing the latest technologies in an innovative way. The international award was announced on February 27 in the award ceremony in Beijing, China. Released in April 2018, Vaisala’s state-of-the-art wireless monitoring system was designed to ensure storage conditions of critical assets in the strictly regulated life science industry like pharmaceutical warehouses, laboratories, freezer rooms and cleanrooms, and provide a gap-free, reliable and easily auditable data of the conditions. Even though designed for regulated environments, the system can be used to monitor variety of applications where the continuous condition monitoring with reliable recorded data play an important role. The awarded
06-03-2019  |  360x  |  Industry news  |   | 
Newcastle Hospitals Improve Patient Recruitment
- With CLiX Software Following the successful conclusion of a pilot study, Clinithink’s CLiX software is now being used by the Newcastle upon Tyne Hospitals NHS Foundation Trust - one of the UK’s leading clinical research centres - to improve patient recruitment in their clinical trials. A strong, collaborative relationship has been established between Clinithink and the Newcastle Hospitals and, as CLiX has made Newcastle a more attractive clinical research site thanks to its improved patient recruitment capabilities, Newcastle is now looking to expand its use of Clinithink’s CLiX software into its non-commercial trial space too. Professor Julia Newton, Deputy Medical Director of Newcastle upon Tyne Hospitals said: “Working with Clinithink has changed how we deliver commercial work. We have topped the NIHR league tables for research for seven consecutive years now, we are proud of how we deliver to time and target, and we are always looking for ways to work better and more efficiently.
06-03-2019  |  322x  |  Industry news
Dolomite Bio unveils new scRNA-Seq Reagent Kit at AGBT2019™
Dolomite Bio unveils new scRNA-Seq Reagent Kit at AGBT2019™
Dolomite Bio, a leading provider of cutting-edge single cell technologies, today announced the launch of a new scRNA-Seq Reagent Kit to expand the Nadia Instrument portfolio. This convenient and cost-effective option is being showcased at the Advances in Genome Biology and Technology 2019 General Meeting (AGBT2019) – February 27th to March 2nd in Marco Island, Florida. The launch of this new reagent kit demonstrates Dolomite Bio’s commitment to the continuous development of the Nadia product family, and provides customers with a high quality, straightforward single cell profiling solution while still offering them the flexibility to use their own reagents if desired. The new scRNA-Seq Reagent Kit is designed to enable robust and reliable generation of PCR­amplified cDNA libraries on the Nadia Instrument, allowing high throughput gene expression profiling of heterogenous cell populations. The kit contains all the consumables required to create amplified cDNA libraries,
01-03-2019  |  286x  |  Industry news  | 
Homology Modeling Homology Modeling | Profacgen
Homology Modeling
Homology Modeling | Profacgen Homology modeling (also known as comparative modeling) is, to date, the most reliable and well-established computational approach for predicting protein structures. In this method, one or more experimental three-dimensional structures of related homologous proteins are identified and used as templates, based on which an atomic-resolution model of the ”target” protein is built from its amino acid sequence. It has been shown that three-dimensional protein structure is evolutionarily more conserved than would be expected on the basis of sequence conservation alone. Thus, even proteins that have diverged appreciably in sequence but still share detectable similarity will also share common structural properties, particularly the overall folding.
01-03-2019  |  437x  |  Product news  | 
First hand experience of the dangers of liquid nitrogen As experienced by Peak Scientific’s Chairman, Robin MacGeachy,
First hand experience of the dangers of liquid nitrogen
As experienced by Peak Scientific’s Chairman, Robin MacGeachy, Labs can remove the dangers of nitrogen cylinders or nitrogen dewars by using a nitrogen generator to supply their instruments. Recently, Peak Scientific’s Founder and Chairman was visiting the Peak Scientific office in Australia. The trip will certainly be memorable as, while visiting a university, a liquid nitrogen dewar fell over into the road, just in front of Robin’s car and started leaking, as pictured on the right. Storing nitrogen in unsecured wheeled nitrogen dewars is dangerous and clearly an accident waiting to happen. Luckily, neither Robin, his passenger or anyone at the University were injured, and Robin’s car also escaped any damage. However, if the accident had happened just a moment later, the outcome could have been very different. Even when liquid nitrogen dewars are properly secured, they are not the safest way to supply nitrogen gas to your laboratory. Storing thousands of litres of pressurized nitrogen can be very dangerous if the dewar or cylinder
01-03-2019  |  297x  |  Industry news  | 
Enzyme Activity Assay Enzyme Activity Assay | Profacgen
Enzyme Activity Assay
Enzyme Activity Assay | Profacgen Enzyme is a large category of bio-molecules that catalyze various biological processes including metabolic processes, cellular signaling and regulation, cell division and apoptosis. Enzymatic reactions convert substrate molecules into chemically modified molecules products with high specificity and accuracy. These modifications include proteolytic digestion, glycolytic degradation, phosphorylation, acylation, glycosylation or oxidative and reductive processes. As play important roles in numerous physiological activities, many of them become critical targets for diseases treatments. For example, matrix metalloproteinase (MMP) plays critical role in anti-tumor metastasis. Protein kinase B (PKB) and protein kinase C (PKC) are major drug targets for clinical treatment of diabetes. HIC and HCV viral proteinase can serve as therapeutic target for antiviral therapy. Cytochrome P450 is a vital enzyme during drug metabolism and has great influence on thermoregulation. Based
01-03-2019  |  263x  |  Product news  | 
ARCHIVE
MAR
2019
FEB
2019
JAN
2019
DEC
2018
NOV
2018
OCT
2018
SEPT
2018
AUG
2018
JULY
2018
JUNE
2018
MAY
2018
APR
2018
MAXUS MEDIA
LABinsights.net LABinsights.de LABinsights.nl
SIGN UP FOR OUR NEWSLETTER
Newsletter archive
Service and contact
ContactDisclaimerPrivacyAdvertising